MolTag

"Ion channels and transporters as molecular drug targets" (MolTag) is a PhD/doctoral program in pharmaceutical sciences established at the University of Vienna, the Medical University of Vienna, the Vienna University of Technology and the Institute of Science and Technology Austria at Klosterneuburg. The graduate program is financed by a research grant of the Austrian Science Fund (FWF) since 2011. MolTag offers a broad three-year PhD education in pharmaceutical sciences including specialized field courses such as molecular pharmacology, pharmacoinformatics, structure-function analysis of target molecules, biophysics, imaging and advanced synthetic chemistry. Applicants at MolTag have completed a diploma study in medicine or a high quality master program in natural sciences, such as pharmacy, biology, molecular biology or chemistry. MolTag provides comprehensive training in relevant research areas of pharmaceutical research, with focus on drug discovery and drug development. MolTag will provide PhD students with contacts to national and international research labs, including the pharmaceutical industry. We aim to create an atmosphere of collaborative and interdisciplinary research.


The MolTag Movie

TEASER (2 min)

Curious to see what the "MolTag PhD program" is all about? With an introduction by our program speaker, Prof. Gerhard Ecker, and a very personal definition of what MolTag means to them by the students, we would like to give here a short glimpse into the MolTag movie.

CELEBRATION OF 10 ys OF MOLTAG (20 min)

The last cohort of MolTag students of the FWF-funded Doctoral Program "Molecular Drug Targets" explain and illustrate their work and research goals on drug targets with their very own interdisciplinary MolTag approach. Under the Corona conditions in 2021, the students have written the script and concept using video chats and shared documents. With professional support for camera and editing, this resulted in an inspiring and enthusiastic film document of the MolTag PhD students of 2021.

The complete film (21 min) illustrates the interdisciplinary research that is pursued in our groups.


 

 

Latest News

18.08.2022
 

In this joint MolTag paper, the authors identified a so far undescribed function of β-subunit homomers as proton-gated anion channels.

 

04.08.2022
 

The award is granted for theses and research work of high topicality that deal with an innovative subject and are of high practical relevance.

01.05.2022
 

Giovanni Di Mauro performed the first offline Moltag defense in this Funding period!

Latest Announcements

16.09.2022
 

“Protein Binding Sites for Drug Discovery” on Oct 13 at UZA2!

06.04.2022
 

Structural mechanisms of ion channel gating, pharmacology, and CNS immune disorders by Ryan Hibbs

04.03.2022
 

"Identification of the long-sought GHB high-affinity binding site in the mammalian brain"